ClinicalTrials.govpublic full text
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
leukemia, chronic myeloid, bcr-abl positive, imatinib, pioglitazone, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906965
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.